PortfolioPlus
Portfolio-Tracker – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
Kiromic BioPharma Forum: Community User: Summer.76
Kommentare 271
Summer.76,
01.11.2021 21:23 Uhr
0
🍀
Summer.76,
28.10.2021 18:18 Uhr
0
Möglicherweise zieht sie noch bissel hoch.
P
Pferdeschwanz,
28.10.2021 18:17 Uhr
0
Bei 3$ hätte icb den Verlust noch verkraftet und wäre wieder unten eingestiegen. Aber jetzt leider wäre der Verlust zu hoch
Summer.76,
28.10.2021 18:14 Uhr
0
Vielleicht ziehst du dann heute die Reissleine?
P
Pferdeschwanz,
25.10.2021 20:24 Uhr
0
Wäre icb docj heute ausgestiegen, jedes Mal das selbe
Summer.76,
25.10.2021 13:39 Uhr
0
Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01, Company’s Phase 1 Cell Therapy Cancer Vaccine Candidate for Solid Tumors
https://www.businesswire.com/news/home/20211025005273/en/Kiromic-BioPharma-Now-Clinical-Stage-Reports-Significant-Progression-Free-Survival-Benefit-in-Metastatic-Pancreatic-Cancer-Patient-Treated-with-KiroVaxBSK01-Company%E2%80%99s-Phase-1-Cell-Therapy-Cancer-Vaccine-Candidate-for-Solid-Tumors
• Progression Free Survival of 7 months after Treatment with KiroVAX/BSK01 and Chemotherapy Versus 3.9 months with Standard of Care
• KiroVax/BSK01 Underscores the Company’s Cellular Therapy Approach to Treating Solid Cancer Tumors
• Advancement of KiroVax/BSK01 Leverages Acceleration of Regulatory Pathways, Improvements in Manufacturing Yield, and Potential as an Adjuvant Treatment to Improve Efficacy of Company’s Broader Pipeline
Summer.76,
11.10.2021 14:17 Uhr
0
Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers
https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers
Alexis ISO-1 is Company’s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers
Company Also Provides Guidance on Regulatory Pathway
Summer.76,
09.09.2021 6:41 Uhr
0
EU Patent #3220913 for "NANOPARTICLE-BASED VACCINE TARGETING CANCER/TESTIS ANTIGENS AND ITS USE IN SOLID MALIGNANCIES"
https://data.epo.org/publication-server/pdf-document?pn=3220913&ki=B1&cc=EP
P
Pferdeschwanz,
19.08.2021 23:47 Uhr
0
Diese **** ke hat mein Leben ruiniert ! **** ceo
Summer.76,
13.08.2021 22:09 Uhr
0
Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights
https://www.businesswire.com/news/home/20210813005386/en/Kiromic-BioPharma-Reports-Second-Quarter-2021-Financial-Results-and-Operating-Highlights
KIROMIC BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
https://www.marketscreener.com/quote/stock/KIROMIC-BIOPHARMA-INC-113902312/news/KIROMIC-BIOPHARMA-Management-s-Discussion-and-Analysis-of-Financial-Condition-and-Results-of-Opera-36161507/
Summer.76,
09.08.2021 22:35 Uhr
0
https://register.epo.org/application?number=EP15861304&tab=main
Summer.76,
04.08.2021 20:47 Uhr
0
https://last10k.com/sec-filings/krbp/0001558370-21-010146.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=krbp
Summer.76,
28.07.2021 22:35 Uhr
0
https://conferencecalltranscripts.com/summary/?id=9698052
Summer.76,
27.07.2021 5:03 Uhr
0
Kiromic Announces the Acquisition of InSilico Solutions Leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors
https://www.businesswire.com/news/home/20210726005822/en/Kiromic-Announces-the-Acquisition-of-InSilico-Solutions-Leveraging-on-Bioinformatics-and-Artificial-Intelligence-to-Advance-Clinical-Development-on-Its-Outpatient-Allogeneic-CAR-T-for-Solid-Tumors
P
Pferdeschwanz,
16.07.2021 22:23 Uhr
0
Ist die ke immer noch net durch oder wie
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | Marvel Hauptdiskussion | -3,65 % | |
| 2 | Iris Energy | -0,82 % | |
| 3 | für alle, die es ehrlich meinen beim Traden. | ||
| 4 | Trading- und Aktien-Chat | ||
| 5 | DAX Prognose / Germany 40 | +0,21 % | |
| 6 | MODERNA INC. DL-,0001 Hauptdiskussion | -4,00 % | |
| 7 | rubrik | -4,59 % | |
| 8 | NVIDIA Hauptdiskussion | +8,26 % | |
| 9 | Micron Neu | -2,44 % | |
| 10 | Surge Digital | +0,55 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | Marvel Hauptdiskussion | -3,41 % | |
| 2 | Iris Energy | -0,71 % | |
| 3 | MODERNA INC. DL-,0001 Hauptdiskussion | -4,00 % | |
| 4 | rubrik | -3,83 % | |
| 5 | NVIDIA Hauptdiskussion | +8,24 % | |
| 6 | Micron Neu | -2,44 % | |
| 7 | Surge Digital | +0,55 % | |
| 8 | TAKE TWO Hauptdiskussion | +0,20 % | |
| 9 | OTL nach dem RS 1:20 | +3,98 % | |
| 10 | NIKE Hauptdiskussion | -0,56 % | Alle Diskussionen |